Keros Therapeutics (KROS) Free Cash Flow (QoQ) (2019 - 2025)
Keros Therapeutics (KROS) Free Cash Flow (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,719.23 Bn | 65,718.94 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 471.85 Bn | 467.06 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.29 Bn | 115.04 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.04 Bn | 61.28 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.06 Bn | 62.06 Bn | - |
| 8 | Argenx Se | 55.78 Bn | 50.60 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.47 Bn | 959.66 Mn |
| 10 | Keros Therapeutics | 383.56 Mn | 96.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -736.74% |
| Sep 30, 2025 | 114.93% |
| Jun 30, 2025 | -118.89% |
| Mar 31, 2025 | 446.90% |
| Dec 31, 2024 | -49.90% |
| Sep 30, 2024 | 24.35% |
| Jun 30, 2024 | 8.85% |
| Mar 31, 2024 | -72.27% |
| Dec 31, 2023 | 24.71% |
| Sep 30, 2023 | -7.30% |
| Jun 30, 2023 | 6.05% |
| Mar 31, 2023 | -59.29% |
| Dec 31, 2022 | 10.02% |
| Sep 30, 2022 | -2.95% |
| Jun 30, 2022 | -1,433.49% |
| Mar 31, 2022 | 92.32% |
| Dec 31, 2021 | -28.86% |
| Sep 30, 2021 | 12.17% |
| Jun 30, 2021 | -62.64% |
| Mar 31, 2021 | -34.09% |